Cargando…

Model for End-Stage Liver Disease, Model for Liver Transplantation Survival and Donor Risk Index as predictive models of survival after liver transplantation in 1,006 patients

OBJECTIVES: Liver transplantation has not increased with the number of patients requiring this treatment, increasing deaths among those on the waiting list. Models predicting post-transplantation survival, including the Model for Liver Transplantation Survival and the Donor Risk Index, have been cre...

Descripción completa

Detalles Bibliográficos
Autores principales: de Camargo Aranzana, Elisa Maria, Coppini, Adriana Zuolo, Ribeiro, Maurício Alves, Massarollo, Paulo Celso Bosco, Szutan, Luiz Arnaldo, Ferreira, Fabio Gonçalves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462569/
https://www.ncbi.nlm.nih.gov/pubmed/26106959
http://dx.doi.org/10.6061/clinics/2015(06)05
_version_ 1782375681668153344
author de Camargo Aranzana, Elisa Maria
Coppini, Adriana Zuolo
Ribeiro, Maurício Alves
Massarollo, Paulo Celso Bosco
Szutan, Luiz Arnaldo
Ferreira, Fabio Gonçalves
author_facet de Camargo Aranzana, Elisa Maria
Coppini, Adriana Zuolo
Ribeiro, Maurício Alves
Massarollo, Paulo Celso Bosco
Szutan, Luiz Arnaldo
Ferreira, Fabio Gonçalves
author_sort de Camargo Aranzana, Elisa Maria
collection PubMed
description OBJECTIVES: Liver transplantation has not increased with the number of patients requiring this treatment, increasing deaths among those on the waiting list. Models predicting post-transplantation survival, including the Model for Liver Transplantation Survival and the Donor Risk Index, have been created. Our aim was to compare the performance of the Model for End-Stage Liver Disease, the Model for Liver Transplantation Survival and the Donor Risk Index as prognostic models for survival after liver transplantation. METHOD: We retrospectively analyzed the data from 1,270 patients who received a liver transplant from a deceased donor in the state of São Paulo, Brazil, between July 2006 and July 2009. All data obtained from the Health Department of the State of São Paulo at the 15 registered transplant centers were analyzed. Patients younger than 13 years of age or with acute liver failure were excluded. RESULTS: The majority of the recipients had Child-Pugh class B or C cirrhosis (63.5%). Among the 1,006 patients included, 274 (27%) died. Univariate survival analysis using a Cox proportional hazards model showed hazard ratios of 1.02 and 1.43 for the Model for End-Stage Liver Disease and the Model for Liver Transplantation Survival, respectively (p<0.001). The areas under the ROC curve for the Donor Risk Index were always less than 0.5, whereas those for the Model for End-Stage Liver Disease and the Model for Liver Transplantation Survival were significantly greater than 0.5 (p<0.001). The cutoff values for the Model for End-Stage Liver Disease (≥29.5; sensitivity: 39.1%; specificity: 75.4%) and the Model for Liver Transplantation Survival (≥1.9; sensitivity 63.9%, specificity 54.5%), which were calculated using data available before liver transplantation, were good predictors of survival after liver transplantation (p<0.001). CONCLUSIONS: The Model for Liver Transplantation Survival displayed similar death prediction performance to that of the Model for End-Stage Liver Disease. A simpler model involving fewer variables, such as the Model for End-Stage Liver Disease, is preferred over a complex model involving more variables, such as the Model for Liver Transplantation Survival. The Donor Risk Index had no significance in post-transplantation survival in our patients.
format Online
Article
Text
id pubmed-4462569
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
record_format MEDLINE/PubMed
spelling pubmed-44625692015-06-26 Model for End-Stage Liver Disease, Model for Liver Transplantation Survival and Donor Risk Index as predictive models of survival after liver transplantation in 1,006 patients de Camargo Aranzana, Elisa Maria Coppini, Adriana Zuolo Ribeiro, Maurício Alves Massarollo, Paulo Celso Bosco Szutan, Luiz Arnaldo Ferreira, Fabio Gonçalves Clinics (Sao Paulo) Clinical Science OBJECTIVES: Liver transplantation has not increased with the number of patients requiring this treatment, increasing deaths among those on the waiting list. Models predicting post-transplantation survival, including the Model for Liver Transplantation Survival and the Donor Risk Index, have been created. Our aim was to compare the performance of the Model for End-Stage Liver Disease, the Model for Liver Transplantation Survival and the Donor Risk Index as prognostic models for survival after liver transplantation. METHOD: We retrospectively analyzed the data from 1,270 patients who received a liver transplant from a deceased donor in the state of São Paulo, Brazil, between July 2006 and July 2009. All data obtained from the Health Department of the State of São Paulo at the 15 registered transplant centers were analyzed. Patients younger than 13 years of age or with acute liver failure were excluded. RESULTS: The majority of the recipients had Child-Pugh class B or C cirrhosis (63.5%). Among the 1,006 patients included, 274 (27%) died. Univariate survival analysis using a Cox proportional hazards model showed hazard ratios of 1.02 and 1.43 for the Model for End-Stage Liver Disease and the Model for Liver Transplantation Survival, respectively (p<0.001). The areas under the ROC curve for the Donor Risk Index were always less than 0.5, whereas those for the Model for End-Stage Liver Disease and the Model for Liver Transplantation Survival were significantly greater than 0.5 (p<0.001). The cutoff values for the Model for End-Stage Liver Disease (≥29.5; sensitivity: 39.1%; specificity: 75.4%) and the Model for Liver Transplantation Survival (≥1.9; sensitivity 63.9%, specificity 54.5%), which were calculated using data available before liver transplantation, were good predictors of survival after liver transplantation (p<0.001). CONCLUSIONS: The Model for Liver Transplantation Survival displayed similar death prediction performance to that of the Model for End-Stage Liver Disease. A simpler model involving fewer variables, such as the Model for End-Stage Liver Disease, is preferred over a complex model involving more variables, such as the Model for Liver Transplantation Survival. The Donor Risk Index had no significance in post-transplantation survival in our patients. Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2015-06 2015-06 /pmc/articles/PMC4462569/ /pubmed/26106959 http://dx.doi.org/10.6061/clinics/2015(06)05 Text en Copyright © 2015 Clinics http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Science
de Camargo Aranzana, Elisa Maria
Coppini, Adriana Zuolo
Ribeiro, Maurício Alves
Massarollo, Paulo Celso Bosco
Szutan, Luiz Arnaldo
Ferreira, Fabio Gonçalves
Model for End-Stage Liver Disease, Model for Liver Transplantation Survival and Donor Risk Index as predictive models of survival after liver transplantation in 1,006 patients
title Model for End-Stage Liver Disease, Model for Liver Transplantation Survival and Donor Risk Index as predictive models of survival after liver transplantation in 1,006 patients
title_full Model for End-Stage Liver Disease, Model for Liver Transplantation Survival and Donor Risk Index as predictive models of survival after liver transplantation in 1,006 patients
title_fullStr Model for End-Stage Liver Disease, Model for Liver Transplantation Survival and Donor Risk Index as predictive models of survival after liver transplantation in 1,006 patients
title_full_unstemmed Model for End-Stage Liver Disease, Model for Liver Transplantation Survival and Donor Risk Index as predictive models of survival after liver transplantation in 1,006 patients
title_short Model for End-Stage Liver Disease, Model for Liver Transplantation Survival and Donor Risk Index as predictive models of survival after liver transplantation in 1,006 patients
title_sort model for end-stage liver disease, model for liver transplantation survival and donor risk index as predictive models of survival after liver transplantation in 1,006 patients
topic Clinical Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462569/
https://www.ncbi.nlm.nih.gov/pubmed/26106959
http://dx.doi.org/10.6061/clinics/2015(06)05
work_keys_str_mv AT decamargoaranzanaelisamaria modelforendstageliverdiseasemodelforlivertransplantationsurvivalanddonorriskindexaspredictivemodelsofsurvivalafterlivertransplantationin1006patients
AT coppiniadrianazuolo modelforendstageliverdiseasemodelforlivertransplantationsurvivalanddonorriskindexaspredictivemodelsofsurvivalafterlivertransplantationin1006patients
AT ribeiromauricioalves modelforendstageliverdiseasemodelforlivertransplantationsurvivalanddonorriskindexaspredictivemodelsofsurvivalafterlivertransplantationin1006patients
AT massarollopaulocelsobosco modelforendstageliverdiseasemodelforlivertransplantationsurvivalanddonorriskindexaspredictivemodelsofsurvivalafterlivertransplantationin1006patients
AT szutanluizarnaldo modelforendstageliverdiseasemodelforlivertransplantationsurvivalanddonorriskindexaspredictivemodelsofsurvivalafterlivertransplantationin1006patients
AT ferreirafabiogoncalves modelforendstageliverdiseasemodelforlivertransplantationsurvivalanddonorriskindexaspredictivemodelsofsurvivalafterlivertransplantationin1006patients